Your browser doesn't support javascript.
loading
Adyuvant Use of Omalizumab in Desensitization to Chemotherapeutics: Beyond IgE-Mediated Reactions.
Prieto-García, A; Rojas-Pérez-Ezquerra, P; Noguerado-Mellado, B; Zambrano, G; Cuevas, C; Juárez, A; Tornero-Molina, P.
Affiliation
  • Prieto-García A; Allergy Department, University Hospital Gregorio Marañón, Madrid, Spain.
  • Rojas-Pérez-Ezquerra P; Institute for Health Research Gregorio Marañón, Madrid, Spain.
  • Noguerado-Mellado B; Allergy Department, University Hospital Gregorio Marañón, Madrid, Spain.
  • Zambrano G; Institute for Health Research Gregorio Marañón, Madrid, Spain.
  • Cuevas C; Allergy Department, University Hospital Gregorio Marañón, Madrid, Spain.
  • Juárez A; Institute for Health Research Gregorio Marañón, Madrid, Spain.
  • Tornero-Molina P; Allergy Department, University Hospital Gregorio Marañón, Madrid, Spain.
J Investig Allergol Clin Immunol ; 33(6): 497-499, 2023 Dec 14.
Article in En | MEDLINE | ID: mdl-37082897
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab Limits: Humans Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab Limits: Humans Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Document type: Article Affiliation country: España